or Try an Advanced Search...

    Immune Disorders Stocks List

    Symbol Grade Name % Change
    NRIX B Nurix Therapeutics, Inc. -2.69
    IMAB B I-Mab 0.56
    BAX C Baxter International Inc. -0.22
    CGEN D Compugen Ltd. -3.54
    BIIB D Biogen Idec Inc. 4.56
    PLX F Protalix BioTherapeutics, Inc. 0.83
    STRO F Sutro Biopharma, Inc. -6.72
    BNTX F BioNTech SE -0.45
    VCNX F Vaccinex, Inc. 0.84
    TRIB F Trinity Biotech plc 0.00
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Medical Instruments & Supplies
    Related Stock Lists: Autoimmune Disorders Biotechnology Medicine Cancer Immunology Antibodies Biopharmaceutical Life Sciences Biology Clinical Medicine Infectious Diseases Lymphoma Monoclonal Antibodies Multiple Sclerosis Antibody Autoimmunity Biomarkers Degenerative Disease Disease Drug Discovery

    Related ETFs - A few ETFs which own one or more of the above listed Immune Disorders stocks.

    Symbol Grade Name Weight
    BBH D Market Vectors Biotech ETF 6.54
    GERM F ETFMG Treatments Testing and Advancements ETF 6.31
    BIS B ProShares UltraShort Nasdaq Biotechnology 6.12
    IBB D iShares Nasdaq Biotechnology Index Fund 4.96
    PBE D PowerShares Dynamic Biotech & Genome 4.73
    View all Immune Disorders ETFs...
    Compare ETFs
    Compare BBH to BIS Compare GERM to IBB Compare IBB to PBE

        Immune Disorders Stocks Recent News

        Date Stock Title
        Apr 24 BIIB Why Biogen Stock Leaped Nearly 5% Higher Today
        Apr 24 BIIB Biogen's Leqembi Commercial Ramp-Up Modest But Up Ticking, Reports Mixed Bag Q1 Earnings
        Apr 24 BIIB Biogen (BIIB) Q1 Earnings Beat, Stock Up on Alzheimer Drug Uptake
        Apr 24 BIIB Biogen (BIIB) Q1 2024 Earnings Call Transcript
        Apr 24 BIIB Biogen: Don’t expect any big acquisitions this year
        Apr 24 BIIB Biogen Inc. (BIIB) Q1 2024 Earnings Call Transcript
        Apr 24 BIIB Biogen Stock Rises After Earnings, Jump in Sales of Alzheimer’s Drug
        Apr 24 BIIB Biogen stock rises on Q1 results, Alzheimer's drug sales
        Apr 24 BIIB Biogen Affirms Guidance After Mixed First Quarter
        Apr 24 BIIB Alzheimer’s Drug Leqembi Sees Sales Pickup, Boosting Biogen Stock
        Apr 24 BIIB Biogen Beats Estimates as Alzheimer’s Drug Gains Traction
        Apr 24 BIIB Biogen (BIIB) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
        Apr 24 BIIB Biogen Inc (BIIB) Q1 2024 Earnings: Mixed Results Amidst Strategic Growth Efforts
        Apr 24 BIIB Biogen sees ‘encouraging’ trends for postpartum depression drug
        Apr 24 BIIB Biogen to invest more in launch of Alzheimer’s drug Leqembi
        Apr 24 BIIB Biogen says uptake for Alzheimer’s therapy is improving
        Apr 24 BIIB Biogen Non-GAAP EPS of $3.67 beats by $0.21, revenue of $2.29B misses by $30M
        Apr 24 BIIB Biogen beats quarterly profit estimates, Alzheimer's drug sales jump
        Apr 24 BIIB Two Notable Biogen Drugs Walloped Sales Forecasts. Will It Be Enough To Reverse Biogen Stock's Decline?
        Apr 24 BIIB Nasdaq Futures Get A Lift From Tesla, Texas Instruments Earnings: Analyst Points To Key Catalyst For Boosting Rally
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Medical Instruments & Supplies
        Related Stock Lists: Autoimmune Disorders Biotechnology Medicine Cancer Immunology Antibodies Biopharmaceutical Life Sciences Biology Clinical Medicine Infectious Diseases Lymphoma Monoclonal Antibodies Multiple Sclerosis Antibody Autoimmunity Biomarkers Degenerative Disease Disease Drug Discovery
        Immune Disorders

        Immune disorders are conditions that occur when the body's immune system is not functioning properly. These disorders can cause the body to be more susceptible to infections, or can cause the body to attack its own cells and tissues. Examples of immune disorders include allergies, asthma, autoimmune diseases, and immunodeficiency disorders.

        Browse All Tags